| John Robert Ameen, MD | |
|
304 Church St, Sweetwater, TN 37874-1181 | |
| (865) 213-8592 | |
| (865) 213-8596 |
| Full Name | John Robert Ameen |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 304 Church St, Sweetwater, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245238112 | NPI | - | NPPES |
| 3097326 | Medicaid | TN | |
| 3032238 | Other | BLUE CROSS OF TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 27274 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John Robert Ameen, MD 304 Church St, Sweetwater, TN 37874-1181 Ph: (865) 213-8592 | John Robert Ameen, MD 304 Church St, Sweetwater, TN 37874-1181 Ph: (865) 213-8592 |
News Archive
Dendritic cells are the body's "watchdogs". They recognize and then degrade pathogens, isolating characteristic fragments that are recognized by the immune system thus triggering targeted responses.
Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for under-served medical needs in neurology and cardiology, announced the completion of the interim analysis of the pivotal efficacy study of olesoxime in the rare neurodegenerative condition Spinal Muscular Atrophy (SMA).
Treating advanced melanoma patients with either a combination of the immunotherapy drugs nivolumab (Opdivo™) and ipilimumab (Yervoy™) or nivolumab alone significantly increases progression-free survival (PFS) over using ipilimumab alone, according to new findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) simultaneously presented today at the American Society of Clinical Oncology (ASCO) annual meeting and published online in the New England Journal of Medicine (NEJM). Examining specific characteristics of each patient's tumor has also given researchers clearer understanding of which patients should receive the combination.
"Why does a 30-year-old hit their foot against the curb in the parking lot and take a half step and recover, whereas a 71-year-old falls and an 82-year-old falls awkwardly and fractures their hip?" asks James Richardson, M.D., professor of physical medicine and rehabilitation at the University of Michigan Comprehensive Musculoskeletal Center.
Capstone Therapeutics announced today it has completed a limited analysis of a subset of data from the second of its two ongoing AZX100 Phase 2a clinical trials in keloid scarring. The clinical trial will continue to its planned 12-month endpoints.
› Verified 1 days ago
David J Creutzinger, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 304 Church St, Sweetwater, TN 37874 Phone: 865-213-8592 Fax: 865-213-8596 | |
Ashlin Martin Paz, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 304 Wright St, Sweetwater, TN 37874 Phone: 865-213-8592 | |
George Vernon Pegram Iii, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 304 Wright St, Sweetwater, TN 37874 Phone: 865-213-8401 Fax: 865-213-8596 | |
Dr. Michele Lynn Tate, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 304 Wright St, Sweetwater, TN 37874 Phone: 865-213-8401 Fax: 865-213-8596 |